No Data
Boji Medical TechnologyLtd's (SZSE:300404) 7.0% YoY Earnings Expansion Surpassed the Shareholder Returns Over the Past Five Years
Is Boji Medical Technology Co.,Ltd.'s (SZSE:300404) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Boji Medical Technology (300404.SZ): has been identified as a national level specialized, special and new "little giant" enterprise.
Gelonghui November 4th | Boji Medical Technology (300404.SZ) announced that recently, Boji Medical Technology Co., Ltd. received the specialized, special and new "Little Giant" enterprise certificate issued by the Ministry of Industry and Information Technology. The validity period of this specialized, special and new "Little Giant" enterprise is 3 years (July 1, 2024 - June 30, 2027).
Boji Medical Technology (300404.SZ) shareholders Zhao Lingli and Fermi No. 13 completed shareholding, totaling a 1.5% reduction in shares.
boji medical technology (300404.SZ) announced that the company has received the unanimous consent of the controlling shareholder and actual controller, Mr. Wang Tingchun...
boji medical technology (300404.SZ): Currently, the company has no research projects on anti-aging drugs.
According to Gelonhui on October 31, boji medical technology (300404.SZ) stated on the investor interaction platform that the company currently has no research projects on anti-aging drugs.
Broge Pharmaceuticals: Report for the third quarter of 2024
Market Cool On Boji Medical Technology Co., Ltd.'s (SZSE:300404) Revenues Pushing Shares 25% Lower
